Health Care: Drugs

Mylan Inc (MYL: NASDAQ)

$31.69 -0.18 | -0.56%
06/19/13 - 11:41 AM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 6.80B 6.13B 5.45B 5.09B
Cost of Sales 3.34B 3.06B 2.81B 2.62B
Gross Operating Profit 3.45B 3.07B 2.64B 2.48B
Selling, General, and Administrative Expenses 1.40B 1.21B 1.09B 1.05B
Research & Development 401.34M 294.73M 282.15M 275.26M
Operating Income before D & A (EBITDA) 1.65B 1.56B 1.27B 1.15B
Depreciation & Amortization 546.60M 510.69M 422.79M 401.16M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 6.56M -14.87M -34.18M 22.12M
Special Income / Charges 0.00 -48.56M -127.06M -225.72M
Total Income Before Interest Expenses (EBIT) 1.11B 990.58M 687.41M 545.47M
Interest Expense 308.70M 335.94M 331.46M 318.50M
Pre-Tax Income 804.08M 654.64M 355.94M 226.98M
Income Taxes 161.14M 115.83M 10.40M -20.77M
Minority Interest 2.08M 1.99M 427.00K 15.18M
Net Income From Continuing Operations 642.93M 536.81M 345.12M 232.57M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 642.93M 536.81M 345.12M 232.57M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 640.85M 536.81M 345.12M 232.57M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 642.93M 585.37M 472.17M 458.29M
Preferred Dividends
Net Income Available To Common 642.93M 536.81M 223.58M 93.54M
Basic EPS from Continuing Ops. 1.54 1.25 0.69 0.31
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.54 1.25 0.69 0.31
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.54 1.25 0.69 0.31
Basic Normalized Net Income/Share 1.54 1.36 0.94 0.61
EPS fr Continuing Ops. 1.52 1.22 0.68 0.30
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.52 1.22 0.68 0.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.52 1.22 0.68 0.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 1.52 1.33 0.93 0.59
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MYL

View All

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases

Partner Headlines for MYL

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter